retatrutide glp-1 gip glucagon triple agonist Dual and Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Structural insights into the triple

What is Retatrutide 20mg being studied for

What to Discuss With Your GP or Prescriber Open communication with your healthcare team is essential for safe, effective treatment

2020;43(Suppl 1):S66-76

The FDA recently announced that it will take decisive steps to restrict GLP-1 active pharmaceutical ingredients intended for use in non-FDA approved compounded drugs that are being mass-marketed by companies. The regulator called out Hims & Hers by name and put other compounding pharmacies on notice, too

Read More About Cold Sores Sources Mayo Clinic

However, there are a few guidelines: You have obesity a body mass index (BMI) of 30 or higher You have prediabetes or diabetes You have weight-related cardiovascular issues You have a history of cardiovascular disease Your weight is causing you discomfort, such as joint pain Please note that BMI numbers are guidelines